Similar articles for PMID: 31099456

Year	Number of Results
1994	1
1997	1
1998	1
2000	1
2001	1
2002	2
2003	3
2004	1
2005	1
2006	7
2007	3
2008	2
2009	4
2010	3
2011	7
2012	11
2013	7
2014	9
2015	9
2016	6
2017	11
2018	17
2019	10
2020	9
2021	8
2022	11
2023	2
2024	0

1

Increased expression of the HDAC9 gene is associated with antiestrogen resistance of breast cancers.

Linares A, Assou S, Lapierre M, Thouennon E, Duraffourd C, Fromaget C, Boulahtouf A, Tian G, Ji J, Sahin O, Badia E, Boulle N, Cavaillès V. Linares A, et al. Mol Oncol. 2019 Jul;13(7):1534-1547. doi: 10.1002/1878-0261.12505. Epub 2019 Jun 12. Mol Oncol. 2019. PMID: 31099456 Free PMC article.

2

Loss of Rho GDIα and resistance to tamoxifen via effects on estrogen receptor α.

Barone I, Brusco L, Gu G, Selever J, Beyer A, Covington KR, Tsimelzon A, Wang T, Hilsenbeck SG, Chamness GC, Andò S, Fuqua SA. Barone I, et al. J Natl Cancer Inst. 2011 Apr 6;103(7):538-52. doi: 10.1093/jnci/djr058. Epub 2011 Mar 29. J Natl Cancer Inst. 2011. PMID: 21447808 Free PMC article.

3

Induction of UDP-glucuronosyltransferase 2B15 gene expression by the major active metabolites of tamoxifen, 4-hydroxytamoxifen and endoxifen, in breast cancer cells.

Chanawong A, Hu DG, Meech R, Mackenzie PI, McKinnon RA. Chanawong A, et al. Drug Metab Dispos. 2015 Jun;43(6):889-97. doi: 10.1124/dmd.114.062935. Epub 2015 Mar 20. Drug Metab Dispos. 2015. PMID: 25795461

4

Histone deacetylase 9 regulates breast cancer cell proliferation and the response to histone deacetylase inhibitors.

Lapierre M, Linares A, Dalvai M, Duraffourd C, Bonnet S, Boulahtouf A, Rodriguez C, Jalaguier S, Assou S, Orsetti B, Balaguer P, Maudelonde T, Blache P, Bystricky K, Boulle N, Cavaillès V. Lapierre M, et al. Oncotarget. 2016 Apr 12;7(15):19693-708. doi: 10.18632/oncotarget.7564. Oncotarget. 2016. PMID: 26930713 Free PMC article.

5

MCAM/CD146 promotes tamoxifen resistance in breast cancer cells through induction of epithelial-mesenchymal transition, decreased ERα expression and AKT activation.

Liang YK, Zeng D, Xiao YS, Wu Y, Ouyang YX, Chen M, Li YC, Lin HY, Wei XL, Zhang YQ, Kruyt FA, Zhang GJ. Liang YK, et al. Cancer Lett. 2017 Feb 1;386:65-76. doi: 10.1016/j.canlet.2016.11.004. Epub 2016 Nov 9. Cancer Lett. 2017. PMID: 27838413 Free article.

6

The branched-chain amino acid transaminase 1 sustains growth of antiestrogen-resistant and ERα-negative breast cancer.

Thewes V, Simon R, Hlevnjak M, Schlotter M, Schroeter P, Schmidt K, Wu Y, Anzeneder T, Wang W, Windisch P, Kirchgäßner M, Melling N, Kneisel N, Büttner R, Deuschle U, Sinn HP, Schneeweiss A, Heck S, Kaulfuss S, Hess-Stumpp H, Okun JG, Sauter G, Lykkesfeldt AE, Zapatka M, Radlwimmer B, Lichter P, Tönjes M. Thewes V, et al. Oncogene. 2017 Jul 20;36(29):4124-4134. doi: 10.1038/onc.2017.32. Epub 2017 Mar 20. Oncogene. 2017. PMID: 28319069

7

Histone deacetylase inhibition and estrogen receptor alpha levels modulate the transcriptional activity of partial antiestrogens.

Margueron R, Duong V, Bonnet S, Escande A, Vignon F, Balaguer P, Cavaillès V. Margueron R, et al. J Mol Endocrinol. 2004 Apr;32(2):583-94. doi: 10.1677/jme.0.0320583. J Mol Endocrinol. 2004. PMID: 15072561

8

MCF7/LCC9: an antiestrogen-resistant MCF-7 variant in which acquired resistance to the steroidal antiestrogen ICI 182,780 confers an early cross-resistance to the nonsteroidal antiestrogen tamoxifen.

Brünner N, Boysen B, Jirus S, Skaar TC, Holst-Hansen C, Lippman J, Frandsen T, Spang-Thomsen M, Fuqua SA, Clarke R. Brünner N, et al. Cancer Res. 1997 Aug 15;57(16):3486-93. Cancer Res. 1997. PMID: 9270017

9

Raptor localization predicts prognosis and tamoxifen response in estrogen receptor-positive breast cancer.

Bostner J, Alayev A, Berman AY, Fornander T, Nordenskjöld B, Holz MK, Stål O. Bostner J, et al. Breast Cancer Res Treat. 2018 Feb;168(1):17-27. doi: 10.1007/s10549-017-4508-x. Epub 2017 Nov 11. Breast Cancer Res Treat. 2018. PMID: 29128895 Free PMC article.

10

Alteration of Y-box binding protein-1 expression modifies the response to endocrine therapy in estrogen receptor-positive breast cancer.

Ito T, Kamijo S, Izumi H, Kohno K, Amano J, Ito K. Ito T, et al. Breast Cancer Res Treat. 2012 May;133(1):145-59. doi: 10.1007/s10549-011-1731-8. Epub 2011 Aug 24. Breast Cancer Res Treat. 2012. PMID: 21863258

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

124 results

Results by year